These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 12412158

  • 21. Isolate local failure after breast-conserving treatment for early breast cancer, about 57 cases.
    Deniaud-Alexandre E, Lauratet B, Lefranc JP, Genestié C, Lerouge D, Moureau-Zabotto L, Touboul E.
    Cancer Radiother; 2004 Apr; 8(2):95-107. PubMed ID: 15063877
    [Abstract] [Full Text] [Related]

  • 22. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R, Peintinger F, Kopp M, Menzel C, Kogelnik HD, Sedlmayer F.
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [Abstract] [Full Text] [Related]

  • 23. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H, Vicini FA, Kestin LL, Goldstein NS, Decker D, Pettinga J, Ingold J, Benitez P, Neumann K, Rebner M, Dekhne N, Martinez A.
    Cancer; 2004 Aug 15; 101(4):713-20. PubMed ID: 15305400
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Results of conservative surgery for limited-sized infiltrating breast cancer: analysis of 962 tested patients: 24 years of experience.
    Vitucci C, Tirelli C, Graziano F, Santoro E.
    J Surg Oncol; 2000 Jun 15; 74(2):108-15. PubMed ID: 10914819
    [Abstract] [Full Text] [Related]

  • 26. Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors.
    Rouzier R, Mathieu MC, Sideris L, Youmsi E, Rajan R, Garbay JR, André F, Marsiglia H, Spielmann M, Delaloge S.
    Cancer; 2004 Sep 01; 101(5):918-25. PubMed ID: 15329898
    [Abstract] [Full Text] [Related]

  • 27. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
    Padmore RF, Fowble B, Hoffman J, Rosser C, Hanlon A, Patchefsky AS.
    Cancer; 2000 Mar 15; 88(6):1403-9. PubMed ID: 10717623
    [Abstract] [Full Text] [Related]

  • 28. Eleven-year follow-up results in the delay of breast irradiation after conservative breast surgery in node-negative breast cancer patients.
    Vujovic O, Yu E, Cherian A, Dar AR, Stitt L, Perera F.
    Int J Radiat Oncol Biol Phys; 2006 Mar 01; 64(3):760-4. PubMed ID: 16246494
    [Abstract] [Full Text] [Related]

  • 29. Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: new primary cancer allows a good prognosis.
    Nishimura S, Takahashi K, Akiyama F, Oguchi M, Tada K, Makita M, Iwase T, Yoshimoto M, Yamashita T, Sakamoto G, Kasumi F.
    Breast Cancer; 2005 Mar 01; 12(2):112-7. PubMed ID: 15858441
    [Abstract] [Full Text] [Related]

  • 30. Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age.
    Schouten van der Velden AP, Peeters PH, Koot VC, Hennipman A.
    Ann Surg Oncol; 2006 Jul 01; 13(7):990-8. PubMed ID: 16788762
    [Abstract] [Full Text] [Related]

  • 31. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
    Tafra L, Essner R, Brenner RJ, Giuliano AE.
    Am Surg; 1996 May 01; 62(5):395-9. PubMed ID: 8615571
    [Abstract] [Full Text] [Related]

  • 32. Early response to neo-adjuvant chemotherapy in carcinoma of the breast predicts both successful breast-conserving surgery and decreased risk of ipsilateral breast tumor recurrence.
    Ishitobi M, Komoike Y, Motomura K, Koyama H, Inaji H.
    Breast J; 2010 May 01; 16(1):9-13. PubMed ID: 19929889
    [Abstract] [Full Text] [Related]

  • 33. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ, Fourquet A, Vicini FA, Haffty B, Taylor M, McCormick B, McNeese M, Pierce LJ, Landmann C, Olivotto IA, Borger J, de La Rochefordiere A, Schultz DJ.
    Cancer; 2001 Mar 15; 91(6):1090-7. PubMed ID: 11267953
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence.
    Shen J, Hunt KK, Mirza NQ, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Ross MI, Ames FC, Feig BW, Singletary SE, Cristofanilli M, Meric-Bernstam F.
    Cancer; 2005 Aug 01; 104(3):479-90. PubMed ID: 15968686
    [Abstract] [Full Text] [Related]

  • 37. Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.
    Laird J, Lok B, Siu C, Cahlon O, Khan AJ, McCormick B, Powell SN, Cody H, Wen HY, Ho A, Braunstein LZ.
    Ann Surg Oncol; 2018 Jan 01; 25(1):154-163. PubMed ID: 29094250
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
    Harms W, Krempien R, Hensley FW, Berns C, Fritz P, Wannenmacher M.
    Strahlenther Onkol; 2002 Nov 01; 178(11):607-14. PubMed ID: 12426671
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.